279 related articles for article (PubMed ID: 31950467)
21. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
22. Atypical Fibroxanthoma Demonstrating HMB45+ Staining.
Sahni VN; Sahni DR; Cassarino DS
Am J Dermatopathol; 2021 Dec; 43(12):e218-e221. PubMed ID: 34132658
[TBL] [Abstract][Full Text] [Related]
23. [Atypical fibroxanthoma of the scalp: overview and recent developments].
Hilgers M; Wahl RU; Megahed M
Hautarzt; 2014 Dec; 65(12):1008-10. PubMed ID: 25392128
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemistry: a useful adjunct in the evaluation of malignant cutaneous spindle cell tumors.
Walker AN; Morton BD
South Med J; 1988 Dec; 81(12):1505-8. PubMed ID: 3201297
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the lymphatic vessel architecture of atypical fibroxanthoma and pleomorphic dermal sarcoma.
Zschoche C; Hamsch C; Kutzner H; Mentzel T; Werchau S; Enk A; Hartschuh W; Hadaschik E; Toberer F
J Am Acad Dermatol; 2014 Oct; 71(4):842-5. PubMed ID: 25219715
[No Abstract] [Full Text] [Related]
26. Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas".
Silvis NG; Swanson PE; Manivel JC; Kaye VN; Wick MR
Am J Dermatopathol; 1988 Feb; 10(1):9-19. PubMed ID: 3177827
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous metaplastic carcinoma: report of a case involving angiosarcoma.
Kantrow SM; Boyd AS
Am J Dermatopathol; 2007 Jun; 29(3):270-3. PubMed ID: 17519625
[TBL] [Abstract][Full Text] [Related]
28. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
29. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
30. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
[TBL] [Abstract][Full Text] [Related]
31. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
33. Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature With Special Emphasis on the Differential Diagnosis.
Tardío JC; Pinedo F; Aramburu JA; Martínez-González MÁ; Arias D; Khedaoui R; Suárez-Massa D; Santonja C
Am J Dermatopathol; 2016 Aug; 38(8):586-92. PubMed ID: 26848640
[TBL] [Abstract][Full Text] [Related]
34. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma.
Nappi O; Wick MR; Pettinato G; Ghiselli RW; Swanson PE
Am J Surg Pathol; 1992 May; 16(5):429-38. PubMed ID: 1599022
[TBL] [Abstract][Full Text] [Related]
35. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report.
Smith-Zagone MJ; Prieto VG; Hayes RA; Timperman WW; Diwan AH
J Cutan Pathol; 2004 Mar; 31(3):284-6. PubMed ID: 14984584
[TBL] [Abstract][Full Text] [Related]
36. Pleomorphic Dermal Sarcoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
[TBL] [Abstract][Full Text] [Related]
37. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
[TBL] [Abstract][Full Text] [Related]
38. Atypical fibroxanthoma: a selective review.
Gru AA; Santa Cruz DJ
Semin Diagn Pathol; 2013 Feb; 30(1):4-12. PubMed ID: 23327726
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous undifferentiated pleomorphic sarcoma is a pleomorphic dermal sarcoma.
Cohen PR
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621710
[TBL] [Abstract][Full Text] [Related]
40. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
Folpe AL; Cooper K
Arch Pathol Lab Med; 2007 Oct; 131(10):1517-24. PubMed ID: 17922587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]